进博会时刻 : 平安好医生携手罗氏制药共筑“医药险生态联盟”

作者：龚作仁文章来源：Laborer

2025-11-10 11:17

作者：龚作仁文章来源：Laborer

2025-11-10 11:17

邦小白快读

全文速览

文章重点介绍了进博会期间平安好医生与罗氏制药中国启动“医药险生态联盟”，推动数字化健康管理。

1. 联盟专注于构建“预防-诊断-治疗-康复”全周期服务，提升病患创新药可及性和支付灵活性，例如家庭医生提供7×24小时用药提醒和治疗跟踪。

2. 政策支持明显，如“十四五”规划强调数字健康是数字经济重要部分，“十五五”规划提出数字健康驱动医疗现代化，确保“信息多跑路，患者少跑腿”。

实操干货包括平安好医生AI赋能服务：AI自研提升复杂疾病方案准确率至90%，实现健康主动管理和小病快速看诊；老龄化加剧养老服务需求，联盟深化肿瘤药物合作。

文章展示了平安好医生与罗氏制药的品牌合作与行业趋势。

1. 品牌营销：共建“医药险生态联盟”，加强合作提升影响力；数字健康服务成为品牌核心，例如平安好医生利用平台优势转变医疗服务方式。

2. 产品研发与定价：深化肿瘤和创新药物合作，扩展全周期健康产品；用户支付意愿高但人均医疗支出低，品牌需优化价格策略。

消费趋势观察：居民健康管理意识增强，养老服务需求急剧增长；用户行为显示对便捷服务的青睐，如可穿戴设备和线上咨询。

渠道建设启示：扩展线上+线下服务网络，结合政策机遇如“十四五”数字健康规划，强化品牌渠道覆盖。

文章突出政策解读与市场机会。

1. 政策解读：《“十四五”数字经济发展规划》首次明确数字健康重要性，“十五五”规划定位其为医疗现代化驱动轮，鼓励远程诊疗模式。

2. 增长市场和需求变化：医疗养老是中国增长最快协同高的行业；居民健康支付意愿上升，但人均支出低；老龄化浪潮推高养老服务需求。

事件应对和机会提示：生态联盟提供合作方式如深化肿瘤药物合作；可学习点包括AI赋能提升服务效率和风险管理；最新商业模式如全周期健康管理服务整合医疗、药品、保险。

风险提示：机会在于响应政策支持增长，正面影响如提升药品可及性；负面风险未提及，但需关注政策合规性。

文章揭示商业机会和数字化启示。

1. 商业机会：医药险生态联盟带动生产合作，例如扩展肿瘤和创新药物领域合作；需求增长源于养老服务加剧和居民健康意识提升。

2. 产品设计和生产需求：聚焦健康服务产品如全周期管理，需注重效率和安全；政策如数字健康规划鼓励设计可穿戴设备。

推进数字化启示：AI科技应用启示如提升准确率至90%，优化生产流程；电商模式整合线上+线下服务，例如远程监测和线上咨询促进效率。

文章提供行业趋势与技术解决方案。

1. 行业发展趋势：政策驱动数字健康崛起如“十四五”和“十五五”规划；银发经济浪潮提升养老服务需求，行业增长协同高。

2. 新技术应用：AI赋能医疗诊断和治疗方案准确率提升；可穿戴设备用于远程监测，实现数据+模型闭环。

客户痛点解决方案：针对看病慢烦问题，提供线上快速看诊和康复跟踪；解决方案如家庭医生7×24小时服务，应对人均医疗支出低挑战。

文章介绍平台创新做法与需求。

1. 平台最新做法：平安好医生加速AI科技赋能全场景医疗，扩展“四到”服务网络；推进线上+线下整合，提升服务可及性。

2. 商业需求与合作：生态联盟响应医药险需求，平台需加强合作方式如深化与罗氏制药合作；招商启示包括整合政策支持机会。

运营管理与风险规避：通过AI自研闭环优化运营如诊断准确率提升；风险管理未提及，但方向在政策合规和用户服务稳定性。

文章揭示产业动向和政策启示。

1. 产业新动向：“医药险生态联盟”创新生态合作；数字健康崛起成为医疗现代化驱动轮，例如远程诊疗成为常态。

2. 新问题与政策启示：人均医疗支出远低于发达国家，揭示改善空间；政策建议如“十四五”规划强化数字健康，启示法规需整合创新模式。

商业模式：全周期健康管理整合预防到康复服务；研究者关注点包括服务可及性提升和老龄化对养老需求的推动。

声明：快读内容全程由AI生成，请注意甄别信息。如您发现问题，请发送邮件至 run@ebrun.com 。

我是品牌商卖家工厂服务商平台商研究者帮我再读一遍。

Quick Summary

The article highlights Ping An Good Doctor and Roche Pharma China's launch of the "Medicine-Insurance Ecosystem Alliance" during the CIIE, aimed at advancing digital health management.

1. The alliance focuses on building a full-cycle service covering "prevention-diagnosis-treatment-rehabilitation" to improve patient access to innovative drugs and payment flexibility, such as family doctors providing 7×24 medication reminders and treatment tracking.

2. Policy support is evident, with the 14th Five-Year Plan emphasizing digital health as a key part of the digital economy, and the 15th Five-Year Plan positioning digital health as a driver of medical modernization to ensure "information travels more, patients travel less."

Practical insights include Ping An Good Doctor's AI-powered services: self-developed AI increases the accuracy of complex disease treatment plans to 90%, enabling proactive health management and quick consultations for minor illnesses. Aging demographics are intensifying demand for elderly care services, prompting the alliance to deepen cooperation in oncology drugs.

The article showcases the brand collaboration between Ping An Good Doctor and Roche Pharma, along with industry trends.

1. Brand marketing: Co-establishing the "Medicine-Insurance Ecosystem Alliance" strengthens partnership and enhances influence; digital health services become a core brand differentiator, exemplified by Ping An Good Doctor leveraging its platform to transform healthcare delivery.

2. Product R&D and pricing: Deepening cooperation in oncology and innovative drugs expands full-cycle health products; while user willingness to pay is high, per capita medical spending remains low, necessitating optimized pricing strategies.

Consumer trend observations: Growing public awareness of health management and a sharp rise in elderly care demand; user behavior favors convenient services like wearables and online consultations.

Channel development insights: Expanding online-offline service networks, aligned with policy opportunities such as the 14th Five-Year Plan for digital health, to strengthen brand channel coverage.

The article emphasizes policy interpretation and market opportunities.

1. Policy insights: The 14th Five-Year Plan for Digital Economy explicitly prioritizes digital health for the first time, while the 15th Five-Year Plan positions it as a driver of medical modernization, encouraging remote diagnosis models.

2. Growth markets and demand shifts: Healthcare and elderly care are among China's fastest-growing and most synergistic industries; public willingness to pay for health is rising, though per capita spending remains low; aging demographics fuel elderly care demand.

Actionable opportunities: The ecosystem alliance offers collaboration models like deepening oncology drug partnerships; key takeaways include AI-driven service efficiency and risk management; emerging business models integrate medical, pharmaceutical, and insurance services into full-cycle health management.

Risk notes: Opportunities lie in aligning with supportive policies to drive growth, with positive impacts such as improved drug accessibility; no negative risks are mentioned, but policy compliance should be monitored.

The article reveals commercial opportunities and digitalization insights.

1. Business opportunities: The Medicine-Insurance Ecosystem Alliance spurs production collaboration, e.g., expanding partnerships in oncology and innovative drugs; demand growth stems from rising elderly care needs and heightened health awareness.

2. Product design and production needs: Focus on health service products like full-cycle management, emphasizing efficiency and safety; policies such as digital health plans encourage designing wearables.

Digitalization takeaways: AI applications boost accuracy to 90%, optimizing production processes; e-commerce models integrate online-offline services, e.g., remote monitoring and online consultations enhance efficiency.

The article outlines industry trends and tech-driven solutions.

1. Industry trends: Policy-driven rise of digital health via the 14th and 15th Five-Year Plans; silver economy waves amplify elderly care demand, fostering high-growth synergy.

2. Tech applications: AI improves diagnostic and treatment plan accuracy; wearables enable remote monitoring, creating a data-model feedback loop.

Client pain point solutions: Address slow, cumbersome healthcare with quick online consultations and rehab tracking; examples include 7×24 family doctor services to counter low per capita medical spending.

The article details platform innovations and demands.

1. Platform strategies: Ping An Good Doctor accelerates AI-powered healthcare across scenarios, expanding its "four-reaching" service network; advances online-offline integration to boost accessibility.

2. Business needs and partnerships: The ecosystem alliance responds to medicine-insurance demands, requiring strengthened collaborations like with Roche Pharma; partnership opportunities include leveraging policy support.

Operations and risk management: AI self-developed loops optimize operations, e.g., higher diagnostic accuracy; risks are unmentioned, but focus areas include policy compliance and service stability.

The article reveals industry shifts and policy implications.

1. Industry developments: The "Medicine-Insurance Ecosystem Alliance" innovates ecosystem collaboration; digital health emerges as a driver of medical modernization, e.g., remote诊疗 becoming routine.

2. New challenges and policy insights: Low per capita medical spending versus developed countries indicates room for improvement; policy recommendations like the 14th Five-Year Plan's digital health focus highlight regulatory needs for innovative models.

Business models: Full-cycle health management integrates prevention-to-rehabilitation services; research focuses include improved service accessibility and aging-driven elderly care demand.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

2025年11月7日，在第八届中国国际进口博览会现场，平安健康互联网股份有限公司（以下简称：平安好医生）与罗氏制药中国等合作伙伴共同启动“医药险生态联盟”，平安好医生CEO何明科，罗氏制药中国全国市场准入副总裁罗丹等企业领导现场参会。据悉，多方将在构建覆盖“预防-诊断-治疗-康复”全周期的健康管理服务体系加强深入合作，未来有望持续改善病患创新药可及性与支付灵活性，为广大用户提供更智能、更便捷的健康管理新体验。

圆桌现场

金融和医疗养老是中国未来规模最大、增长最快、且协同性高的两大行业。随着中国家庭财富积累日益增长，居民的健康管理意识以及为健康付费意愿也在快速提高。但从全球来看，中国人均医疗支出目前仍远低于发达国家水平。其次，国内老龄化的加剧，银发经济浪潮已来临，养老服务需求也在急剧增长。

《“十四五”数字经济发展规划》首次提及“加快发展数字健康服务”，从政策角度明确将数字健康作为数字经济的重要组成部分。十五五规划建议中，也特别强调“数字健康是打造具有中国特色的现代化医疗卫生体系的驱动轮之一”，远程诊疗、线上健康咨询、智慧医院、可穿戴设备监测等，让“信息多跑路，患者少跑腿”将成为常态，极大提升医疗服务的可及性和便捷性。平安好医生作为平安集团医疗养老生态的旗舰，近年来充分发挥平台优势，以科技驱动，将医疗服务从“被动治疗”转变为“主动管理”，致力于为患者提供贯穿疾病预防、诊断、治疗、康复的全周期健康管理服务。

平安好医生CEO何明科现场表示，在持续打通线上+线下服务能力和扩展“四到”服务网络同时，公司正加速AI科技赋能，不断应用到全场景的医疗、健康，养老业务应用中。患者可更好体验到“健康主动管，小病快速看，大病精准转，慢病管全程”全生命周期健康旅程。举个例子，平安好医生的家庭医生会主动跟踪患者的治疗进展，为患者提供7×24小时的用药提醒、症状监测、报告分析和康复进度跟踪，确保治疗效果的持续性和稳定性。伴随AI自研能力的突破，通过跑通“数据+模型+场景”闭环，平安好医生在复杂疾病MDT治疗方案准确率已逐年提升至目前的近90%；作为普通患者，动动手指即可告别曾经的看病慢、看病烦、看不好病的老大难问题。

平安好医生CEO何明科

近年来，平安好医生与罗氏制药中国在流感创新药、肿瘤特药等领域已建立了坚实的合作基础，未来将继续拓展在肿瘤及创新药物领域的深度合作，共同探索更完善的数字健康管理解决方案。

据悉，平安好医生在医疗健康养老服务领域深耕多年，积累了丰富的技术赋能、用户规模和优质服务经验，此次与罗氏制药中国共建“医药险生态联盟”，标志着双方在构建医疗健康新生态方面迈出了更坚实的一步。这不仅是一次业务合作，更是对“健康中国2030”战略的积极践行。通过进博会这一国际平台，平安好医生将携手更多行业伙伴，共同推进“健康中国2030”规划纲要的践行实施。

注：文/龚作仁，文章来源：Laborer，本文为作者独立观点，不代表亿邦动力立场。

【版权提示】亿邦动力倡导尊重与保护知识产权。未经许可，任何人不得复制、转载、或以其他方式使用本网站的内容。如发现本站文章存在版权问题，烦请提供版权疑问、身份证明、版权证明、联系方式等发邮件至run@ebrun.com，我们将及时沟通与处理。

已点赞

好文章,值得被更多人看到

FAQ回顾

平安好医生与罗氏制药建立的医药险生态联盟主要合作内容是什么？

双方将在第八届进博会启动合作，重点构建覆盖‘预防-诊断-治疗-康复’全周期的健康管理服务体系，提升创新药可及性与支付灵活性，并在肿瘤及创新药物领域深化数字健康解决方案。

平安好医生如何利用AI科技改善医疗服务体验？

平安好医生通过AI赋能实现‘健康主动管、小病快速看、大病精准转、慢病管全程’的服务模式，其复杂疾病MDT治疗方案准确率已提升至近90%，并提供7×24小时家庭医生跟踪服务。

医药险生态联盟的建立有哪些政策背景支持？

该联盟响应《“十四五”数字经济发展规划》对数字健康的强调，以及‘健康中国2030’战略要求，旨在通过数字化提升医疗服务的可及性和便捷性。

标签:: 业界

泰国封杀电商低价进口 1泰铢起征点“掀翻”小卖家饭碗

近日泰国海关宣布，从2026年1月1日开始，将对通过网络平台订购的进口商品统一征收关税，即便是进口价仅1 泰铢的最低限度商品，也将不再享受免税待遇。

泰国海外即时消费新消费

2025-11-10 10:50:09